We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 10 for:    2013001
Previous Study | Return to List | Next Study

Non-Inferiority Quantitative Transmission Ultrasound Case Collection Study (QTUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02133417
Recruitment Status : Completed
First Posted : May 8, 2014
Last Update Posted : May 9, 2018
Sponsor:
Information provided by (Responsible Party):
QT Ultrasound LLC

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Conduct a case collection study of breast imaging examinations from women with mammographically-detected breast lesions for the purpose of conducting subsequent Reader Studies.

Condition or disease Intervention/treatment
Mass Lesion Device: Quantitative Transmission Ultrasound

Detailed Description:

This is a prospective case collection study for the purpose of collecting cases for the subsequent Reader Studies at a minimum of two clinical sites.

Potential subjects will be recruited from a group of women who have undergone diagnostic mammography and demonstrate a mammographic lesion in at least one view. Approximately 300 women will be enrolled. Subjects will undergo QTUS following a diagnostic XRM with a mammographically-detected lesion(s) in at least one mammographic view and will have a lesion seen on HHUS corresponding to the XRM lesion(s). Potential Subjects will be eligible for enrollment at the time the corresponding lesion is identified on HHUS. All subjects will undergo an ultrasound guided aspiration/biopsy with cytology to determine whether the lesion is a cyst or solid.

Each study site is projected to collect approximately 75 cyst cases and 75 solid cases for a total of 150 cases, stratified across the four (4) recognized breast tissue density categories with at least 50% of cases from subjects with heterogeneous and extremely dense breast compositions. The composition of the cyst cases at each site is projected to consist of 25 simple cysts and 50 complicated and complex cysts for a total of 75 cyst cases. All enrolled subjects will undergo ultrasound guided aspiration or biopsy or surgical excision, as applicable for the index lesion. Cytologic or histologic results for all lesions will be performed and collected.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 287 participants
Observational Model: Case-Crossover
Time Perspective: Prospective
Official Title: A Prospective Multi-center Case Collection Study of Breast Imaging Examinations From Women With Mammographically-detected Lesion(s) to Evaluate the Non-inferiority of Digital Mammography (XRM) and Quantitative Transmission Ultrasound (QTUS) Together Compared to XRM and Hand Held Ultrasound (HHUS) Together in the Evaluation of Lesion(s) Detected With Diagnostic Mammography.
Study Start Date : July 2014
Actual Primary Completion Date : December 2015
Actual Study Completion Date : January 2016
Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Women
Women with mammographically-detected breast lesions
 Device: Quantitative Transmission Ultrasound
Quantitative Transmission Ultrasound (QTUS) as an automated breast ultrasound procedure for women who have a mammographically detected mass.
Other Names:
  • QTUS
  • QT Ultrasound


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. The purpose of the case collection study is to collect mammographically-detected breast lesions seen in at least one mammographic view in the clinical setting and seen on HHUS, and confirmed by pathology. [ Time Frame: 12 months ]
    This is a prospective Case Collection study for the purpose of conducting subsequent Reader Studies. The primary objective for this prospective case collection study is to provide up to 300 cytology/pathology confirmed cases for subsequent Reader Studies.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   25 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Eligibility for enrollment will be open to women of all races and ethnicities who have completed a diagnostic XRM with a mammographically-detected lesion(s) in at least one mammographic view and have a lesion seen on HHUS corresponding to the XRM lesion(s). Women with a normal mammogram at the time of this evaluation are not eligible to participate. Women younger than 25 years of age will not be eligible to participate. Potential subjects must not be breastfeeding at the time of diagnostic breast imaging. Patients who have had breast cancer, breast surgeries, or interventional breast procedures in the past 12 months will not be eligible to enter the study.
Criteria

Inclusion Criteria:

  • Female
  • Age 25 or older
  • A bra cup size of A through DDD
  • Willing and able to provide written, signed Informed Consent Form (ICF) after the nature of the study has been explained, all questions have been answered, and prior to any research-related procedure(s)
  • Willing and able to comply with all study procedure(s), including possible aspiration for a simple cyst
  • Complete digital mammography views Craniocaudal and Medio-lateral Oblique (CC and MLO) for one or both breasts
  • Mammographically-detected lesion(s) seen on at least one mammographic view and a corresponding HHUS correlate(s)

Exclusion Criteria:

  • Does not meet all Inclusion Criteria
  • Currently breastfeeding
  • History of breast cancer in the past 12 months, except for Fine Needle Aspirations (FNA) or Cyst Aspiration
  • History of breast surgeries or interventional breast procedures in the past 12 months
  • Normal mammogram at the time of this evaluation
  • Physical inability to tolerate the procedure on the scanner, i.e. inability to lie prone and still for up to 30 minutes at a time
  • Open wounds, sores or skin rash present on the breast(s) or nipple discharge from the scanned breast
  • Breasts too large for scanner, i.e. bra size larger than DDD or inability to successfully "fit" breast after the subject is placed on scanner
  • Body weight greater than 400 lbs. (180 kg)
  • Has a concurrent disease or condition which in the judgment of the principal investigator disqualifies the subject, from participating in the study
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02133417


Locations
Layout table for location information
United States, District of Columbia
George Washington University Medical Center
Washington, District of Columbia, United States, 20037
United States, New York
Elizabeth Wende Breast Care, LLC
Rochester, New York, United States, 14620
Sponsors and Collaborators
QT Ultrasound LLC
Investigators
Layout table for investigator information
Study Director: Rajni Natesan, MD Chief Medical Officer
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: QT Ultrasound LLC
ClinicalTrials.gov Identifier: NCT02133417    
Other Study ID Numbers: 2013001
First Posted: May 8, 2014    Key Record Dates
Last Update Posted: May 9, 2018
Last Verified: May 2018
Keywords provided by QT Ultrasound LLC:
Quantitative Transmission Ultrasound
QTUS